Further, a recent study demonstrated that COPB2 could be a potential target gene in prostate cancer.5 Loss of function experiments demonstrated that COPB2 downregulation arrests the cell cycle at G1 and G2 phases and induces cell apoptosis. The gene discussed is COPB2; the disease is prostate carcinoma.